Breaking News Instant updates and real-time market news.

PANW

Palo Alto Networks

$209.90 /

+0.515 (+0.25%)

, ZS

Zscaler

$47.72 /

-0.5 (-1.04%)

11:25
10/10/19
10/10
11:25
10/10/19
11:25

FBN Securities network security/IT security to hold a luncheon meeting

Network Security Analysts hold an industry luncheon meeting with security channel executive Jim Gruzelwski in New York on October 10 at 12 pm hosted by FBN Securities.

PANW

Palo Alto Networks

$209.90 /

+0.515 (+0.25%)

ZS

Zscaler

$47.72 /

-0.5 (-1.04%)

SYMC

Symbol changed to NLOK

$23.62 /

+0.09 (+0.38%)

FTNT

Fortinet

$77.73 /

-0.16 (-0.21%)

CHKP

Check Point

$109.51 /

-0.64 (-0.58%)

FEYE

FireEye

$14.69 /

+0.16 (+1.10%)

PFPT

Proofpoint

$127.89 /

+0.51 (+0.40%)

OKTA

Okta

$116.76 /

-1.44 (-1.22%)

CSCO

Cisco

$46.05 /

-0.76 (-1.62%)

PSTG

Pure Storage

$16.99 /

+0.64 (+3.91%)

NTNX

Nutanix

$23.95 /

+ (+0.00%)

NTAP

NetApp

$50.26 /

-1.12 (-2.18%)

VMW

VMware

$152.15 /

+0.05 (+0.03%)

CTXS

Citrix

$97.19 /

+0.63 (+0.65%)

  • 10

    Oct

  • 11

    Oct

  • 14

    Oct

  • 15

    Oct

  • 24

    Oct

  • 24

    Oct

  • 28

    Oct

  • 31

    Oct

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 12

    Dec

  • 16

    Dec

PANW Palo Alto Networks
$209.90 /

+0.515 (+0.25%)

10/02/19 SunTrust
SunTrust initiates infrastructure and security sector
10/02/19 SunTrust
Palo Alto Networks initiated with a Buy at SunTrust
09/24/19 Berenberg
Zscaler upgraded to Buy from Hold at Berenberg
09/19/19 BofA
Check Point downgraded to Underperform from Buy at BofA/Merrill
ZS Zscaler
$47.72 /

-0.5 (-1.04%)

10/02/19 SunTrust
Zscaler initiated with a Buy at SunTrust
09/11/19 Credit Suisse
Zscaler price target lowered to $70 from $78 at Credit Suisse
SYMC Symbol changed to NLOK
$23.62 /

+0.09 (+0.38%)

10/09/19 Morgan Stanley
CIOs see continued pressure on IT budgets in 2020, says Morgan Stanley
09/13/19 KeyBanc
Broadcom price target raised to $340 from $330 at KeyBanc
09/09/19 Wells Fargo
Symantec Consumer Cyber Safety a candidate to be taken private, says Wells Fargo
08/30/19 Macquarie
Macquarie sees limited impact on Crowdstrike from Carbon Black buyout
FTNT Fortinet
$77.73 /

-0.16 (-0.21%)

08/02/19
Fortinet upgraded to Buy at BofA/Merrill on 'solid' execution in Q2
08/02/19 BofA
Fortinet upgraded to Buy from Neutral at BofA/Merrill
06/24/19 JPMorgan
Fortinet upgraded to Overweight from Neutral at JPMorgan
CHKP Check Point
$109.51 /

-0.64 (-0.58%)

10/08/19
Fly Intel: Top five analyst downgrades
10/07/19 Jefferies
Check Point downgraded to Hold from Buy at Jefferies
10/07/19 Jefferies
Check Point downgraded to Hold from Buy at Jefferies
FEYE FireEye
$14.69 /

+0.16 (+1.10%)

10/03/19 Dougherty
FireEye exploring a sale 'would make a lot of sense,' says Dougherty
10/02/19 SunTrust
FireEye initiated with a Hold at SunTrust
08/06/19
Fly Intel: Top five analyst initiations
PFPT Proofpoint
$127.89 /

+0.51 (+0.40%)

10/02/19 SunTrust
Proofpoint initiated with a Hold at SunTrust
09/04/19 Deutsche Bank
Proofpoint upgraded to Buy from Hold at Deutsche Bank
08/13/19 BofA
Crowdstrike price target raised to $103 from $89 at BofA/Merrill
OKTA Okta
$116.76 /

-1.44 (-1.22%)

10/04/19 Deutsche Bank
Okta could exceed 41% growth expectations for fiscal 2020, says Deutsche Bank
10/03/19
Fly Intel: Top five analyst upgrades
10/02/19 SunTrust
SunTrust upgrades Okta to Buy on expectations of 30%-plus sales growth
10/02/19 SunTrust
Okta upgraded to Buy from Hold at SunTrust
CSCO Cisco
$46.05 /

-0.76 (-1.62%)

10/10/19
Fly Intel: Top five analyst downgrades
10/10/19 Goldman Sachs
Cisco downgraded to Neutral from Buy at Goldman Sachs
09/23/19 Northland
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans
PSTG Pure Storage
$16.99 /

+0.64 (+3.91%)

10/10/19 Goldman Sachs
Pure Storage upgraded to Buy from Neutral at Goldman Sachs
09/18/19 Cross Research
Pure Storage upgraded to Buy from Hold at Cross Research
09/18/19 William Blair
Pure Storage a 'tremendously underappreciated growth story,' says William Blair
09/12/19 Piper Sandler
Pure Storage price target raised to $21 from $16 at Piper Jaffray
NTNX Nutanix
$23.95 /

+ (+0.00%)

09/09/19 Susquehanna
Nutanix upgraded two notches to Positive from Negative at Susquehanna
09/05/19
Nutanix a 'strong acquisition candidate' for Google, says Trefis
08/29/19 Baird
Nutanix price target lowered to $29 from $41 at Baird
08/29/19 Wells Fargo
Nutanix price target lowered to $25 form $33 at Wells Fargo
NTAP NetApp
$50.26 /

-1.12 (-2.18%)

10/10/19 Goldman Sachs
NetApp downgraded to Sell from Buy at Goldman Sachs
09/30/19 Morgan Stanley
NetApp checks show sequential decrease in storage demand, says Morgan Stanley
09/09/19 Susquehanna
Susquehanna upgrades NetApp to Positive, boosts target to $75 from $54
09/09/19 Susquehanna
NetApp upgraded to Positive from Neutral at Susquehanna
VMW VMware
$152.15 /

+0.05 (+0.03%)

10/08/19 Jefferies
VMware assumed with a Buy rating at Jefferies
10/01/19
Fly Intel: Top five analyst upgrades
10/01/19 Wells Fargo
Wells Fargo upgrades VMware to Outperform, boosts price target to $180
CTXS Citrix
$97.19 /

+0.63 (+0.65%)

10/08/19 Jefferies
Citrix assumed with an Underperform rating at Jefferies
07/25/19 Stifel
Faster than expected subscription transition pressuring Citrix, says Stifel
07/25/19 Jefferies
Citrix shares remain overvalued after Q2 miss, says Jefferies
06/06/19 Deutsche Bank
Deutsche Bank upgrades Citrix on 'under the radar' desktop strength

TODAY'S FREE FLY STORIES

Recommendations
Kraft debt downgrades assures higher borrowing costs, says Stifel » 13:05
02/17/20
02/17
13:05
02/17/20
13:05
KHC

Kraft Heinz

$26.88 /

-0.895 (-3.22%)

Stifel analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
General Motors to cease Holden sales, design/engineering operations by 2021 » 13:04
02/17/20
02/17
13:04
02/17/20
13:04
GM

General Motors

$34.76 /

-0.535 (-1.52%)

General Motors said it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
S&P lowers Kraft Heinz long-term issuer credit rating to 'BB+' » 13:01
02/17/20
02/17
13:01
02/17/20
13:01
KHC

Kraft Heinz

$26.88 /

-0.895 (-3.22%)

S&P Global Ratings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Summary: The pound ebbed some, and the Canadian dollar firmed some » 13:00
02/17/20
02/17
13:00
02/17/20
13:00

FX Summary: The pound…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Teva price target raised to $14 from $8 at UBS » 12:56
02/17/20
02/17
12:56
02/17/20
12:56
TEVA

Teva

$12.21 /

-0.36 (-2.86%)

UBS analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Infosys upgraded to Buy from Neutral at Goldman Sachs » 12:53
02/17/20
02/17
12:53
02/17/20
12:53
INFY

Infosys

$11.02 /

-0.08 (-0.72%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Bombardier sells rail business to Alstom for $8.2B » 12:48
02/17/20
02/17
12:48
02/17/20
12:48
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

, ALSMY

Alstom

$0.00 /

+ (+0.00%)

Bombardier (BDRBF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Siemens upgraded to Buy from Hold at Nord/LB » 12:43
02/17/20
02/17
12:43
02/17/20
12:43
SIEGY

Siemens

$0.00 /

+ (+0.00%)

Nord/LB analyst Wolfgang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Oil Action: Front-month WTI prices are flat » 09:45
02/17/20
02/17
09:45
02/17/20
09:45

Oil Action: Front-month…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar and most other currencies have been stable » 07:55
02/17/20
02/17
07:55
02/17/20
07:55

FX Update: The dollar and…

FX Update: The dollar and most other currencies have been stable in quiet early-week trading so far. This came with the main Chinese equity indices posting 2%-plus gains after China's Finance Minister said on Sunday that Beijing would roll out targeted and phased tax and fee cuts and with the PBoC lowering one of its interest rates and making another liquidity injection. Other stock markets in Asia were mixed, while European markets posted modest gains. The number of new cases in the coronavirus continued to increase, though the consensus view seems to remain that peak contagion will likely been seen in March. Japan's Nikkei 225 underperformed, closing with a 0.7% loss following weaker than expected Q4 GDP data, which showed a 1.6% q/q contraction versus the median forecast for -0.9%. Q3 data were also revised down, and the data come amid expectations for a dismal current quarter performance given the impact of measures to contain the virus outbreak in China and Japan, and elsewhere. Among the main currencies, EUR-USD has been plying a narrow range just above the 34-month seen on Friday at 1.0827. USD-JPY has posted a sub-15 pip range just below Friday's 107.91 peak so far. Cable has continued to consolidate gains seen mid last week following signs that the government is gearing up a fiscally expansive policy. The pair has been holding with about 1.3030-50, off from the two-week high of last Thursday at 1.3069. AUD-USD has traded slightly firmer, managing to lift just above its Friday high in making a peak at 0.6733. USD-CAD edged out a two-week low, at 1.3225. A big focus will be on flash manufacturing PMI surveys for February, due at the end of the week out of Eurozone, UK and U.S. Note that U.S. and Canadian markets are closed today.

Conference/Events
Azure Power management to meet with Roth Capital » 04:55
02/17/20
02/17
04:55
02/17/20
04:55
AZRE

Azure Power

$13.70 /

+0.21 (+1.56%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD edged out a two-week low » 04:00
02/17/20
02/17
04:00
02/17/20
04:00

FX Action: USD-CAD edged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar and most other currencies have been stable » 03:40
02/17/20
02/17
03:40
02/17/20
03:40

FX Update: The dollar and…

FX Update: The dollar and most other currencies have been stable in quiet early-week trading so far. This came with the main Chinese equity indices posting 2%-plus gains after China's Finance Minister said on Sunday that Beijing would roll out targeted and phased tax and fee cuts and with the PBoC lowering one of its interest rates and making another liquidity injection. Other stock markets in Asia were mixed. The number of new cases in the coronavirus continued to increased, though the consensus view seems to remain that peak contagion will likely been seen in March. Japan's Nikkei 225 underperformed, closing with a 0.7% loss following weaker than expected Q4 GDP data, which showed a 1.6% q/q contraction versus the median forecast for -0.9%. Q3 data were also revised down, and the data come amid expectations for a dismal current quarter performance given the impact of measures to contain the virus outbreak in China and Japan, and elsewhere. Among the main currencies, EUR-USD has been plying a narrow range just above the 34-month seen on Friday at 1.0827. EUR-JPY and EUR-CHF have been doing likewise about their respective four-month and five-year lows of Friday. USD-JPY has posted a sub-15 pip range just below Friday's 107.91 peak so far. Cable has continued to consolidate gains seen mid last week following signs that the government is gearing up a fiscally expansive policy. The pair has been holding with about 1.3030-50, off from the two-week high of last Thursday at 1.3069. AUD-USD has traded slightly firmer, managing to lift just above its Friday high in making a peak at 0.6733. USD-CAD edged out a two-week low, at 1.3233. A big focus will be on flash manufacturing PMI surveys for February, due at the end of the week out of Eurozone, UK and U.S. Note that U.S. markets will be closed today.

General news
Asian Market Update: » 03:05
02/17/20
02/17
03:05
02/17/20
03:05

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Paramount Group management to meet with Morgan Stanley » 16:42
02/16/20
02/16
16:42
02/16/20
16:42
PGRE

Paramount Group

$14.84 /

+0.15 (+1.02%)

Group Dinner Meeting with…

Group Dinner Meeting with President & CEO Behler and CFO Paes will be held in New York on February 25 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
8x8, Inc. management to meet with Morgan Stanley » 16:38
02/16/20
02/16
16:38
02/16/20
16:38
EGHT

8x8, Inc.

$20.41 /

-0.25 (-1.21%)

Meeting to be held in New…

Meeting to be held in New York on February 20 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Bausch Health management to meet with Morgan Stanley » 16:36
02/16/20
02/16
16:36
02/16/20
16:36
BHC

Bausch Health

$27.74 /

+0.305 (+1.11%)

Meeting to be held in New…

Meeting to be held in New York on February 19 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Piper Sandler biotech analyst to hold a KOL luncheon » 16:04
02/16/20
02/16
16:04
02/16/20
16:04

Analysts hold a GU…

Analysts hold a GU Oncology Key Opinion Leader Luncheon Meeting with Dr. Arjun Bala in New York on February 21 hosted by Piper Sandler.

Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call » 16:03
02/16/20
02/16
16:03
02/16/20
16:03

Alternative Energy &…

Alternative Energy & Environmental Services Analyst Windham discusses advanced nuclear energy systems with TerraPower on an Analyst/Industry conference call to be held on February 24 at 11 am.

Conference/Events
Cowen Washington policy strategist to hold an analyst/industry conference call » 16:01
02/16/20
02/16
16:01
02/16/20
16:01

Washington Research…

Washington Research Policy Strategist Krueger holds U.S. Blues: Delegate Download--Morning After (Nevada) Analyst/Industry conference call to be held on February 24 at 10:30 am.

Conference/Events
Stephens oil and gas analysts to hold an analyst/industry conference call » 15:59
02/16/20
02/16
15:59
02/16/20
15:59

Oil & Gas Analysts,…

Oil & Gas Analysts, along with Brandon Barnes, Senior Analyst for Bloomberg Intelligence, discuss the current state of the energy-related infrastructure in North America, with a specific focus on oil & gas pipeline construction on an Analyst/Industry conference call to be held on February 18 at 11 am.

Conference/Events
Cantor Fitzgerald biotech & specialty pharma analysts to hold a luncheon » 15:57
02/16/20
02/16
15:57
02/16/20
15:57
PFE

Pfizer

$36.49 /

-0.43 (-1.16%)

, LLY

Eli Lilly

$141.13 /

-0.75 (-0.53%)

, DERM

Dermira

$18.75 /

+0.01 (+0.05%)

, REGN

Regeneron

$399.34 /

+0.57 (+0.14%)

, INCY

Incyte

$78.42 /

+0.34 (+0.44%)

, ARNA

Arena Pharmaceuticals

$54.01 /

+0.18 (+0.33%)

Specialty Pharma Analyst…

Specialty Pharma Analyst Chen, Biotech Analysts Young & Merle, along with Key Opinion Leaders Dr. Goldberg, Skin Laser & Surgery Specialists of NY & NJ and Dr. Weinberg, Forest Hills Dermatology Group, discuss the competitive landscape in atopic dermatitis at a Group Luncheon Meeting being held at Cantor's New York offices on February 24 at 12 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cellcom Israel announces negotiations to purchase Golan Telecom » 15:27
02/16/20
02/16
15:27
02/16/20
15:27
CEL

Cellcom Israel

$4.04 /

-0.08 (-1.94%)

Cellcom Israel announced…

Cellcom Israel announced that it is in negotiations with Golan Telecom's, or Golan Telecom, shareholders, in regards to possible purchase of its holdings in Golan Telecom. The company added that it cannot guarantee that such discussions will mature into a transaction.

Hot Stocks
Bristol-Myers announced five-year follow-up results from Phase 3 CheckMate -025 » 15:25
02/16/20
02/16
15:25
02/16/20
15:25
BMY

Bristol-Myers

$66.38 /

+0.31 (+0.47%)

Bristol-Myers Squibb…

Bristol-Myers Squibb announced five-year follow-up results from the Phase 3 CheckMate -025 study, which continue to demonstrate that treatment with Opdivo delivers superior overall survival and objective response rates in patients with previously treated advanced or metastatic renal cell carcinoma compared to those treated with everolimus. With an extended minimum follow-up of 64 months, patients treated with Opdivo continue to demonstrate OS benefit with 26% of patients alive compared to 18% of patients treated with everolimus. Additionally, the percentage of patients experiencing an objective response was 23% for Opdivo versus 4% for everolimus and the median duration of response for Opdivo was also maintained longer than for everolimus. The overall safety profile was consistent with that observed in previously reported analyses from CheckMate -025 in patients with RCC. No new safety signals or drug-related deaths occurred with extended follow-up.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Bristol-Myers announced updated results from Phase 3 CheckMate -214 study » 15:23
02/16/20
02/16
15:23
02/16/20
15:23
BMY

Bristol-Myers

$66.38 /

+0.31 (+0.47%)

Bristol-Myers Squibb…

Bristol-Myers Squibb announced updated results from the Phase 3 CheckMate -214 study evaluating the combination of Opdivo plus Yervoy versus sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma. With a minimum follow-up of 42 months, the combination of Opdivo plus Yervoy continues to show superior overall survival, objective response rates, duration of response and complete response rates. The safety profile for Opdivo plus Yervoy was consistent with prior findings and no new safety signals or drug-related deaths occurred with extended follow-up. A significant OS benefit was observed in both patients from the intermediate- and poor-risk and the intent-to-treat populations treated with Opdivo plus Yervoy compared to those treated with sunitinib alone. Of the patients treated with Opdivo plus Yervoy who experienced a complete response, per independent review, that response was ongoing in 84% and 86% of patients in the IP and ITT populations, respectively.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.